
Ask a doctor about a prescription for Calsus
the user
Cholecalciferol
Calsus contains the active substance cholecalciferol (vitamin D), which regulates the absorption and metabolism of calcium and bone mineralization. Calsus is used to prevent and treat vitamin D deficiency in adults and adolescents (children over 12 years of age). Calsus is also used as a supplement to proper treatment of bone loss (osteoporosis) in adult patients, preferably in combination with calcium.
If any of the above applies to you, consult your doctor or pharmacist before taking Calsus. 1/5
Before starting treatment with Calsus, discuss it with your doctor or pharmacist:
This medicine is not intended for use in children under 12 years of age.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take, especially:
Swallow the Calsus capsule whole with water, preferably during a meal.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Calsus is not recommended during pregnancy. Calsus can be used during breastfeeding. Vitamin D passes into breast milk. This should be taken into account when giving additional vitamin D to a breastfed child. There are no data on the effect of vitamin D on fertility. However, it is not expected that normal vitamin D levels will have any adverse effect on fertility. 2/5
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist. Swallow the capsules whole with water. It is best to take Calsus with a meal to help your body absorb the vitamin D.
Prevention of vitamin D deficiency
The recommended dose is one capsule (25,000 IU) per month.
Initial treatment of vitamin D deficiency
The dose will be adjusted according to the patient's blood vitamin D levels (25-hydroxycholecalciferol (25(OH)D)).
The recommended dose is 100,000 IU (4 capsules of 25,000 IU) taken once in the first month.
A maintenance dose of one capsule of 25,000 IU per month may be considered after the initial dose of 100,000 IU.
Calsus used as a supplement to proper treatment of osteoporosis in adult patients
The recommended dose is one capsule (25,000 IU) per month.
Calsus in the form of 25,000 IU capsules is not intended for use in children under 12 years of age. Other forms of this medicine may be more suitable for children. Consult your doctor or pharmacist.
If you take more than you should, contact your doctor or emergency department immediately for assessment of the risk and advice. The most common symptoms of overdose are: nausea, vomiting, excessive thirst, increased urination within 24 hours, constipation, and dehydration, as well as high blood calcium levels (hypercalcemia and hypercalciuria) confirmed by laboratory tests.
Do not take a double dose to make up for a forgotten dose.
If you want to stop taking this medicine, discuss it with your doctor. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop taking Calsus and contact your doctor immediately if you experience symptoms of a severe allergic reaction such as:
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, PL-02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP". The expiry date refers to the last day of that month. Store the medicine below 25°C. Store in the original package to protect from moisture. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is cholecalciferol (vitamin D). Each soft capsule contains 0.625 mg of cholecalciferol, equivalent to 25,000 IU of vitamin D. The other ingredients are: capsule filling: medium-chain triglycerides, all-rac-α-tocopherol (E 307). Capsule shell: gelatin, glycerol, purified water, titanium dioxide (E 171), and yellow iron oxide (E 172). Also contains traces of medium-chain triglycerides, phosphatidylcholine (from soybean lecithin - see section 2 "Calsus contains soybean lecithin"), caprylic and capric triglycerides, ethanol, sunflower seed oil glycerides, oleic acid, ascorbyl palmitate, and all-rac-α-tocopherol.
Calsus, 25,000 IU, soft capsules, are yellow, opaque, oval-shaped soft gelatin capsules, approximately 9 mm x 6 mm in size. PVC/PVDC/Aluminum blisters in a cardboard box. Packs of 1, 2, 3, 4, 6, and 12 soft capsules, as well as packs of 3x1, 4x1, 6x1, 12x1 soft capsules. Not all pack sizes may be marketed.
Teva B.V., Swensweg 5, 2031 GA Haarlem, The Netherlands
TEVA Gyógyszergyár Zrt., Pallagi út 13, 4042 Debrecen, Hungary, Merckle GmbH, Ludwig-Merckle-Strasse 3, 89143 Blaubeuren, Germany. For more information on this medicine, contact the marketing authorization holder: Teva Pharmaceuticals Polska Sp. z o.o., tel. +48 22 345 93 00
5/5
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Calsus – subject to medical assessment and local rules.